We are live on ! Find out more
ROIV icon

Roivant Sciences

147 hedge funds and large institutions have $3.39B invested in Roivant Sciences in 2023 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 57 increasing their positions, 19 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more call options, than puts

Call options by funds: $4.77M | Put options by funds: $1.19M

292% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 13

200% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 19

34% more funds holding

Funds holding: 110147 (+37)

3.8% more ownership

Funds ownership: 56.78%60.57% (+3.8%)

3% more capital invested

Capital invested by funds: $3.29B → $3.39B (+$100M)

9% less funds holding in top 10

Funds holding in top 10: 1110 (-1)

Holders
147
Holders Change
+37
Holders Change %
+33.64%
% of All Funds
2.34%
Holding in Top 10
10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-9.09%
% of All Funds
0.16%
New
51
Increased
57
Reduced
19
Closed
13
Calls
$4.77M
Puts
$1.19M
Net Calls
+$3.58M
Net Calls Change
+$1.58M
Name Holding Trade Value Shares
Change
Change in
Stake
Zurich Cantonal Bank
101
Zurich Cantonal Bank
Switzerland
$329K +$33K +4,010 +10%
VEA
102
Virtus ETF Advisers
New York
$315K +$6.22K +755 +2%
EFM
103
E Fund Management
China
$313K +$241K +29,236 +223%
Mackenzie Financial
104
Mackenzie Financial
Ontario, Canada
$304K +$339K +41,195 New
Mitsubishi UFJ Asset Management
105
Mitsubishi UFJ Asset Management
Japan
$303K +$18K +2,189 +6%
PCM
106
Prelude Capital Management
New York
$301K +$162K +19,700 +93%
PFO
107
Pathstone Family Office
New Jersey
$284K -$317K -38,488 -50%
PAMS
108
Pictet Asset Management (Switzerland)
Switzerland
$228K
CCM
109
CTC Capital Management
Illinois
$199K +$222K +27,000 New
SC
110
Shay Capital
New York
$185K +$206K +25,000 New
Amundi
111
Amundi
France
$180K +$20K +2,433 +11%
SAM
112
Sectoral Asset Management
Quebec, Canada
$155K
Allianz Asset Management
113
Allianz Asset Management
Germany
$146K +$163K +19,800 New
CSS
114
Cubist Systematic Strategies
Connecticut
$135K +$60.6K +7,355 +67%
Verition Fund Management
115
Verition Fund Management
Connecticut
$118K +$131K +15,946 New
TRCT
116
Tower Research Capital (TRC)
New York
$108K +$102K +12,353 +532%
VPIM
117
Vanguard Personalized Indexing Management
California
$104K +$116K +14,079 New
Daiwa Securities Group
118
Daiwa Securities Group
Japan
$102K +$17.6K +2,132 +18%
Handelsbanken Fonder
119
Handelsbanken Fonder
Sweden
$100K
VRS
120
Virginia Retirement Systems
Virginia
$95.9K +$107K +13,000 New
CA
121
Cetera Advisors
Colorado
$90K +$100K +12,200 New
New York State Common Retirement Fund
122
New York State Common Retirement Fund
New York
$89.8K +$100K +12,171 New
First Manhattan
123
First Manhattan
New York
$81.2K +$90.6K +11,000 New
TC
124
TwinBeech Capital
New York
$81K +$90.3K +10,970 New
CUAMC
125
China Universal Asset Management Company
China
$75.8K +$23.9K +2,907 +39%

ROIV Hedge Fund Activity: Q1 2023 in Review

147 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q1 2023, worth a combined $3.39B — up 3% from $3.29B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new ROIV positions and 13 closed out — a net gain of 38 holders — while 57 added to existing stakes and 19 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $99M. The largest seller was SB Investment Advisers (UK), cutting an estimated $98.8M.

  • 147 institutional investors held Roivant Sciences (ROIV) as of Q1 2023, up from 110 in Q4 2022.
  • Funds reported $3.39B of Roivant Sciences stock for Q1 2023, up 3% quarter-over-quarter.
  • 51 funds opened new Roivant Sciences positions in Q1 2023 and 13 closed out, a net change of +38 holders.
  • The largest Roivant Sciences buyer in Q1 2023 was Wellington Management Group, an estimated $99M added.
  • The largest Roivant Sciences seller in Q1 2023 was SB Investment Advisers (UK), an estimated $98.8M sold.

Based on aggregated 13F filings for Q1 2023.